Gene News and Research

Latest Gene News and Research

CSHL publishes 'The Mammary Gland as an Experimental Model' book

Studies of mammary gland biology are essential in the fight against breast cancer. Moreover, the mammary gland represents an excellent model system for investigation of physiological and pathological processes that occur throughout the body.

4 Oct 2011

Researchers identify specific molecule that alters how breast cancer cells move

Researchers from the University of Michigan Comprehensive Cancer Center have identified a specific molecule that alters how breast cancer cells move. This affects the cells' ability to spread or metastasize to distant parts of the body, the hallmark of deadly, aggressive cancer.

4 Oct 2011

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA and mRNA-targeted therapies, today announced the Company will report new clinical data results from the miravirsen Phase 2a proof-of-concept study to treat patients infected with the Hepatitis C virus (HCV) in a late-breaking oral presentation session at the American Association for the Study of Liver Diseases (AASLD) 2011 annual meeting.

4 Oct 2011

Discovery of ‘alarm-clock’ gene

Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body’s biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.

3 Oct 2011

Novel drug shows promise for MLL leukemia

According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.

3 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Potential new drug could treat mixed-lineage leukaemia

A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies, according to a study published in Nature today.

3 Oct 2011

Researchers identify unusual genomic architecture linked with very severe forms of disease

When cells divide normally, DNA gets copied perfectly and distributed among the daughter cells with an even hand. Occasionally though, DNA breaks during division and is rearranged, resulting in duplications or deletions of important parts of the blueprint.

3 Oct 2011

Scientists discover 16 million SNPs that associate with increased risk of ovarian cancer

Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain and Finland today report the discovery of variants in the human genome that associate with increased risk of invasive ovarian cancer, one of the deadliest forms of cancer in women.

3 Oct 2011

Combination of P16 immunohistochemistry, DNA qPCR can accurately detect oropharyngeal cancer

Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinoma, a form of head and neck cancer, which derive from HPV16, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

3 Oct 2011

WSU to help develop alternatives to petroleum-based fuels and chemicals

U.S. Department of Agriculture Secretary Tom Vilsack yesterday announced that Washington State University (WSU) will receive a five-year, $40 million grant to help develop alternatives to petroleum-based fuels and chemicals.

3 Oct 2011

Palmetto establishes formal coverage policy for all Medicare patients

Genomic Health, Inc. today announced that Palmetto GBA, the designated national contractor for its Oncotype DX colon cancer test, has established a formal coverage policy for all Medicare patients.

1 Oct 2011

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

1 Oct 2011

Less toxic amounts of chemotherapy medicine slows tumor growth: Scientists

University of Georgia scientists have found that smaller, less toxic amounts of chemotherapy medicine given frequently to mice with human prostate cancer noticeably slowed tumor growth.

1 Oct 2011

Third Annual Cape Cod Walk 'n' Roll for FSH Muscular Dystrophy on October 1

Tomorrow, October 1, 2011, FSHD patients and their friends, advocates, and families will join in the Third Annual Cape Cod Walk 'n' Roll for FSHD.

1 Oct 2011

Researchers identify gene responsible for starting the biological clock

Ever wondered why you wake up in the morning ---- even when the alarm clock isn't making jarring noises? Wonder no more. Researchers at the Salk Institute for Biological Studies have identified a new component of the biological clock, a gene responsible for starting the clock from its restful state every morning.

1 Oct 2011

Novel bipartite gene therapy for retinitis pigmentosa

In a paper published in the October 2011 issue of Experimental Biology and Medicine, a team of researchers at Columbia University Medical Center led by Stephen Tsang, MD, Ph.D have achieved temporary functional preservation of photoreceptors in a mouse model for retinitis pigmentosa (RP) using novel bipartite gene therapy.

1 Oct 2011

ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA

ViroPharma Incorporated today announced the license of worldwide rights from Intellect Neurosciences, Inc. to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's Ataxia (FA), a rare, hereditary, progressive neurodegenerative disease.

1 Oct 2011

Blueberry powder may control triple negative breast cancer

In several studies recently conducted at the Beckman Research Institute at the City of Hope, Duarte, CA researchers found that feeding blueberry powder to mice significantly reduced the growth and spread of triple negative breast cancer cells, a very aggressive form of cancer.

1 Oct 2011

European and North American scientists to explore biology of heart failure

A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.

1 Oct 2011

Gene News and Research

Latest Gene News and Research

CSHL publishes 'The Mammary Gland as an Experimental Model' book

Researchers identify specific molecule that alters how breast cancer cells move

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Discovery of ‘alarm-clock’ gene

Novel drug shows promise for MLL leukemia

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Potential new drug could treat mixed-lineage leukaemia

Researchers identify unusual genomic architecture linked with very severe forms of disease

Scientists discover 16 million SNPs that associate with increased risk of ovarian cancer

Combination of P16 immunohistochemistry, DNA qPCR can accurately detect oropharyngeal cancer

WSU to help develop alternatives to petroleum-based fuels and chemicals

Palmetto establishes formal coverage policy for all Medicare patients

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Less toxic amounts of chemotherapy medicine slows tumor growth: Scientists

Third Annual Cape Cod Walk 'n' Roll for FSH Muscular Dystrophy on October 1

Researchers identify gene responsible for starting the biological clock

Novel bipartite gene therapy for retinitis pigmentosa

ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA

Blueberry powder may control triple negative breast cancer

European and North American scientists to explore biology of heart failure

eBook: Using iPSCs models for human disease research and drug discovery eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development